Meeting Report

Nuances in the Management of Aggressive Lymphomas

Presented by Paul A. Hamlin, MD, and Michelle Wisniewski, MS, PA-C

Memorial Sloan Kettering Cancer Center, New York New York

Presenters’ disclosures of potential conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2017;8:279–284 | https://doi.org/10.6004/jadpro.2017.8.3.11 | © 2017 Harborside Press®


  

ABSTRACT

Treatment for both Hodgkin and Non-Hodgkin lymphoma now includes chemotherapy, targeted therapy, and new immunotherapies. As research continues to shine the light on tumor genetics, clinical variability, and new treatment approaches, advanced practitioners need to translate this information in the management of aggressive lymphomas.


For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here